Top news of the week in oncology and cancer drug development.
The Akt protein is crucial for T cells to transform into memory T cells.
Parameters used to calculate direct and indirect remuneration fees may not apply to specialty pharmacies.
SF2523 can dually inhibit a protein and an enzyme associated with cancer.
Prescription drug spending expected to increase from 2017 to 2025 due to costly specialty drugs.
Cannabidiol found in cannabis could be used as a novel treatment for hepatitis C virus
Top news of the week from Specialty Pharmacy Times.

Product News

Granix is a human granulocyte factor produced in a bioreactor using recombinant DNA technology.
Complera treats HIV infection in previously untreated adults with a viral load of 100,000 copies/mL or less.
Repatha (evolocumab) treats primary hyperlipidemia in combination with dietary measures and maximally tolerated doses of statins.
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) is approved for treatment of HIV-1 infection.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Intellisphere, LLC. All Rights Reserved.